Providing complex support in analytics and bioanalytics of large molecules, a BioPharma department’s capabilities help get more efficient drugs to patients and subsequently improve quality of life.

An essential part of QUINTA-ANALYTICA’s service portfolio, its BioPharma team offers comprehensive support via the testing of large, more complex pharmaceutical products such as peptides, proteins, monoclonal antibodies, and antibody-drug conjugates.

Led by Milan Madera, who has a strong background in characterization using chromatographic and mass spectrometric techniques, the dept. is equipped with modern high resolution/high mass accuracy LC-MS/MS, capillary electrophoresis designed for biopharma applications, and ELISA readers with a state-of-the-art MSD electrochemiluminescence platform which allows for immunogenicity testing of therapeutic drugs.

Despite being the newest dept. of Quinta, its operation in R&D, GMP, GLP, and GCP regimes help clients through the development and validations of methods not only for routine analysis of therapeutic products but also as bioanalytical support for preclinical and clinical testing.

If you’re looking for characterization of complex analytes or their quantification in various biological matrices, get in touch with Milan or the rest of the team today.

Additional News

  • 19 December 2023

    Happy new year 2024

    As we bid farewell to 2023, it's time to express our deepest gratitude for the collaboration.

  • 4 December 2023

    Our new clinical unit in Ostrava comes to life

    It's a great pleasure to announce that after two years of hard work, the brand-new clinical unit in Ostrava with 36-beds capacity has been opened.

  • 3 October 2023

    Meet us at the heart of Pharma, CPHI 2023

    Quinta-Analytica is attending CPHI 2023 in Barcelona